Singapore markets open in 1 hour 33 minutes

Eli Lilly and Company (LLY)

NYSE - Nasdaq Real-time price. Currency in USD
Add to watchlist
295.19-6.21 (-2.06%)
At close: 04:04PM EDT
295.00 -0.19 (-0.06%)
After hours: 07:21PM EDT
Full screen
Trade prices are not sourced from all markets
Previous close301.40
Bid293.64 x 800
Ask295.69 x 1100
Day's range294.03 - 302.43
52-week range193.11 - 314.00
Avg. volume2,967,843
Market cap280.478B
Beta (5Y monthly)0.43
PE ratio (TTM)43.87
Earnings dateN/A
Forward dividend & yield3.92 (1.34%)
Ex-dividend date13 May 2022
1y target estN/A
  • Zacks

    AstraZeneca (AZN) Inks Deal to Develop COVID-19 Antibodies

    AstraZeneca (AZN) partners with a U.K.-based biotech company to develop monoclonal antibodies targeting the COVID-causing virus.

  • Motley Fool

    Why Eli Lilly Stock Climbed Today

    Shares of Eli Lilly (NYSE: LLY) rose on Monday after the U.S. Food and Drug Administration (FDA) approved the pharmaceutical giant's new diabetes treatment, tirzepatide. As of 1:50 p.m. ET, Eli Lilly's stock price was up more than 3%. A phase 3 clinical trial showed tirzepatide to reduce A1C -- a key measure of average blood sugar levels -- better than existing treatment options.

  • Zacks

    Lilly's (LLY) Diabetes Treatment Tirzepatide Gets FDA Nod

    Lilly's (LLY) Mounjaro (tirzepatide) is a novel diabetes treatment, which has shown impressive blood sugar reductions and weight loss in a broad range of type II diabetes patients in the SURPASS studies.